Intero Biosystems offers lab-grown mini intestines to replace animal tests
🤖 This content was generated and summarized with AI assistance based on the linked source — it is not a substitute for the original or professional advice.
Original source:techcrunch.com
Key Takeaways
- Intero Biosystems produces miniature, lab-grown human intestinal tissues called organoids to test pharmaceutical compounds.
- The startup aims to bypass the inaccuracies of animal testing by using models that more closely mirror human physiology.
- U.S. Food and Drug Administration policy changes are driving broader industry acceptance of non-animal testing alternatives.
- The company plans to scale automated production and eventually expand into personalized medicine applications.
Intero Biosystems is addressing the high failure rate of pharmaceutical drugs by providing laboratory-grown human intestinal organoids. These tiny tissues allow researchers to evaluate safety and efficacy more accurately than traditional animal models, as they better reflect human biology.
Regulatory shifts, including updated U.S. Food and Drug Administration guidelines, are encouraging developers to adopt alternative testing methodologies. The startup currently supplies thousands of these living models to industry clients while working toward mass production, custom testing services, and future personalized medicine applications.
Want to go deeper?
Join an interactive study discussion — ask questions, challenge, and explore.
Recommended for you
Tools and services we trust to boost productivity and content workflows.
Browse picks